Immunosuppressive Drug Optimization and Monitoring - Organ Transplantation Drugs

Organ transplantation is the strategy of choice for end-stage organ disease. Immunosuppressive therapies have allowed patients to extend the life of the organ but require careful monitoring to prevent toxicity and rejection. Therapeutic choice should be carefully considered based on the clinical setting, and blood levels should be carefully monitored for adequate dosing and toxicity. Important factors include the organ transplanted, time posttransplant, age and clinical status of the patient, metabolic pathways, liver and kidney function, and concomitant medications.

Tabs Content
Content Review: 
August 2017

Last Update: October 2019